Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lavae-Mokhtari (Ibbenbueren, Germany), A. Akil (Ibbenbueren, Germany), D. Wehde (Ibbenbueren, Germany), M. Semik (Ibbenbueren, Germany), S. Fischer (Ibbenbueren, Germany), N. Dickgreber (Ibbenbueren, Germany). SCLC stage limited and very limited Disease with and without operation. 4671

Member's Comments

No comment yet.

Related content which might interest you: Disease relapse in surgically and conservatively treated patients with stage I-II of non-small cell lung cancer Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Timing of radiotherapy and possible survival benefit in limited disease SCLC patients Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy? Source: ERJ Open Res, 6 (1) 00159-2019; 10.1183/23120541.00159-2019 Year: 2020 Stage I-IIIa small cell lung cancer (SCLC): multimodal therapy including surgery Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Outcomes of radical treatment of early stage non-small cell lung cancer Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 A single centre review of palliative chemotherapy in newly diagnosed stage IIIb and IV lung cancer patients with good performance status Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Disease relapse after radical surgery of NSCLC Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007 Quality of life evolution in the first year after VATS lung resection and SABR for early stage NSCLC: a single centre analysis Source: Virtual Congress 2020 – Challenging issues in thoracic surgery Year: 2020 Main reasons for a low accrual pattern in clinical trials of patients with advanced stage non-small cell lung cancer (NSCLC) Source: Annual Congress 2008 - Influence of teaching models on skills and knowledge of medical doctors Year: 2008 Impact of early weight loss during concurrent chemoradiotherapy on survival in advanced stage NSCLC patients Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Quality indicators in lung cancer care-review of resection rates in early stage NSCLC (non small cell lung cancer) at King’s Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018 MDT interaction in two comparable NSCLC stage IIIA patients Source: International Congress 2015 – Lung cancer: the need for a multidisciplinary approach - an interactive session Year: 2015 Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018 Quality of life assessment in advanced stage of lung cancer patients before and after chemotherapy Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Clinico-pathological prognostic factors for relapse in early stage non-small cell lung cancer after radical surgical resection Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013